Changes in estrogen-sensitive hemostatic biomarkers (nAPCsr, nTM sr, and SHBG), among controls
| . | Controls (n = 28) . | |||||
|---|---|---|---|---|---|---|
| nAPCsr . | nTMsr . | SHBG [nmol/L] . | ||||
| n . | Mean (SD) . | n . | Mean (SD) . | n . | Mean (SD) . | |
| Baseline | 17 | 1.09 (0.42) | 27 | 1.00 (0.50) | 28 | 61.8 (34.7) |
| 4 wk | 16 | 1.03 (0.33) | 28 | 0.98 (0.63) | 28 | 63.5 (34.7) |
| 12 wk | 18 | 0.89 (0.39) | 27 | 1.02 (0.56) | 28 | 61.9 (38.3) |
| . | Controls (n = 28) . | |||||
|---|---|---|---|---|---|---|
| nAPCsr . | nTMsr . | SHBG [nmol/L] . | ||||
| n . | Mean (SD) . | n . | Mean (SD) . | n . | Mean (SD) . | |
| Baseline | 17 | 1.09 (0.42) | 27 | 1.00 (0.50) | 28 | 61.8 (34.7) |
| 4 wk | 16 | 1.03 (0.33) | 28 | 0.98 (0.63) | 28 | 63.5 (34.7) |
| 12 wk | 18 | 0.89 (0.39) | 27 | 1.02 (0.56) | 28 | 61.9 (38.3) |